Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives ; volume:9 ; number:1 ; day:7 ; month:5 ; year:2020 ; pages:1-11 ; date:12.2020
Translational neurodegeneration ; 9, Heft 1 (7.5.2020), 1-11, 12.2020
- Urheber
-
Cheng, Yuan
Tian, Ding-Yuan
Wang, Yan-Jiang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-020-00195-1
- URN
-
urn:nbn:de:101:1-2020071419443431908714
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cheng, Yuan
- Tian, Ding-Yuan
- Wang, Yan-Jiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation